2023-04-27T13:43:11+08:00 weekly 1.0 https://srla.jiuyuangene.net/ 2023-11-24T16:22:31+08:00 weekly 0.9 https://srla.jiuyuangene.net/download 2025-10-18T08:40:35+08:00 weekly 0.9 https://srla.jiuyuangene.net/about-us 2022-03-18T19:29:20+08:00 weekly 0.9 https://srla.jiuyuangene.net/contact-us 2021-12-27T21:05:41+08:00 weekly 0.9 https://srla.jiuyuangene.net/inquiry 2021-12-27T21:05:28+08:00 weekly 0.9 https://srla.jiuyuangene.net/newslist-1 2021-12-27T21:05:33+08:00 weekly 0.9 https://srla.jiuyuangene.net/info/ 2021-12-27T21:05:31+08:00 weekly 0.9 https://srla.jiuyuangene.net/products 2021-12-27T21:03:21+08:00 weekly 0.9 https://srla.jiuyuangene.net/finished-dosage-form/ 2021-12-27T21:03:23+08:00 weekly 0.9 https://srla.jiuyuangene.net/finished-dosage-form/recombinant-diabetes-injection/ 2021-12-27T21:03:24+08:00 weekly 0.9 https://srla.jiuyuangene.net/finished-dosage-form/oncology-injection/ 2021-12-27T21:03:24+08:00 weekly 0.9 https://srla.jiuyuangene.net/finished-dosage-form/medical-device/ 2021-12-27T21:03:26+08:00 weekly 0.9 https://srla.jiuyuangene.net/finished-dosage-form/anticoagulant-injection/ 2021-12-27T21:03:26+08:00 weekly 0.9 https://srla.jiuyuangene.net/ap/ 2021-12-27T21:03:28+08:00 weekly 0.9 https://srla.jiuyuangene.net/ap/recombinant-diabetes-api/ 2021-12-27T21:03:29+08:00 weekly 0.9 https://srla.jiuyuangene.net/ap/oncology-api/ 2021-12-27T21:03:29+08:00 weekly 0.9 https://srla.jiuyuangene.net/ap/medical-device-api/ 2021-12-27T21:03:31+08:00 weekly 0.9 https://srla.jiuyuangene.net/ap/anticoagulant-api/ 2023-04-25T17:17:52+08:00 weekly 0.8 https://srla.jiuyuangene.net/finished-dosage-form/recombinant-diabetes-injection/semaglutide-injection-diabetes-recombinant.html 2023-04-25T17:17:50+08:00 weekly 0.8 https://srla.jiuyuangene.net/finished-dosage-form/recombinant-diabetes-injection/liraglutide-injection-recombinant-route.html 2023-04-25T17:17:53+08:00 weekly 0.8 https://srla.jiuyuangene.net/finished-dosage-form/recombinant-diabetes-injection/dulaglutide-injection-diabetes-recombinant.html 2023-04-25T17:17:59+08:00 weekly 0.8 https://srla.jiuyuangene.net/finished-dosage-form/oncology-injection/rhil-11-injection-oprelvekin-cas-no-145941-26.html 2023-04-25T17:17:54+08:00 weekly 0.8 https://srla.jiuyuangene.net/finished-dosage-form/oncology-injection/fulvestrant-injection-an-anti-cancer-drug-cas.html 2023-04-25T17:18:02+08:00 weekly 0.8 https://srla.jiuyuangene.net/finished-dosage-form/oncology-injection/palonosetron-hydrochloride-injection-anti.html 2023-04-25T17:18:01+08:00 weekly 0.8 https://srla.jiuyuangene.net/finished-dosage-form/oncology-injection/rhg-csf-injection-filgrastim-recombinant.html 2023-04-25T17:18:01+08:00 weekly 0.8 https://srla.jiuyuangene.net/finished-dosage-form/oncology-injection/pegfilgrastim-injection-a-long-lasting-rhg.html 2023-04-25T17:17:59+08:00 weekly 0.8 https://srla.jiuyuangene.net/finished-dosage-form/oncology-injection/fosaprepitant-dimeglumine-injection-cas-no.html 2023-04-25T17:18:03+08:00 weekly 0.8 https://srla.jiuyuangene.net/finished-dosage-form/oncology-injection/daratumumab-injection-multiple-myeloma-cd-38.html 2023-04-25T17:18:05+08:00 weekly 0.8 https://srla.jiuyuangene.net/finished-dosage-form/medical-device/rhbmp-2-recombinant-human-bone-morphogenetic.html 2023-04-25T17:18:07+08:00 weekly 0.8 https://srla.jiuyuangene.net/finished-dosage-form/anticoagulant-injection/enoxaparin-sodium-injection-anticoagulant-and.html 2023-04-25T17:18:05+08:00 weekly 0.8 https://srla.jiuyuangene.net/finished-dosage-form/anticoagulant-injection/avatrombopag-maleate-thrombocytopenia-cas-no.html 2021-12-23T05:05:50+08:00 weekly 0.8 https://srla.jiuyuangene.net/ap/recombinant-diabetes-api/liraglutide-recombinant-route-diabetes-bulk.html 2022-10-18T06:46:27+08:00 weekly 0.8 https://srla.jiuyuangene.net/ap/recombinant-diabetes-api/semaglutide-diabetes-recombinant-route.html 2022-10-18T06:46:29+08:00 weekly 0.8 https://srla.jiuyuangene.net/ap/recombinant-diabetes-api/dulaglutide-diabetes-recombinant-route.html 2022-10-18T06:46:31+08:00 weekly 0.8 https://srla.jiuyuangene.net/finished-dosage-form/oncology-injection/fulvestrant-an-anti-cancer-drug-cas-no-129453.html 2021-12-23T05:05:50+08:00 weekly 0.8 https://srla.jiuyuangene.net/ap/oncology-api/rhil-11-oprelvekin-a-drug-to-increase.html 2021-12-23T05:05:50+08:00 weekly 0.8 https://srla.jiuyuangene.net/ap/oncology-api/rhg-csf-filgrastim-recombinant-human.html 2022-10-18T06:46:32+08:00 weekly 0.8 https://srla.jiuyuangene.net/ap/oncology-api/fosaprepitant-dimeglumine-cas-no-265121-04-8.html 2021-12-23T05:05:50+08:00 weekly 0.8 https://srla.jiuyuangene.net/ap/oncology-api/palonosetron-hydrochloride-anti-emesis-after.html 2022-10-18T06:46:31+08:00 weekly 0.8 https://srla.jiuyuangene.net/ap/oncology-api/pegfilgrastim-a-long-lasting-rhg-csf-cas-no.html 2022-10-18T06:46:33+08:00 weekly 0.8 https://srla.jiuyuangene.net/ap/oncology-api/daratumumab-multiple-myeloma-cd-38-mab-cas-no.html 2023-04-25T17:18:11+08:00 weekly 0.8 https://srla.jiuyuangene.net/ap/medical-device-api/rhbmp-2-recombinant-human-bone-morphogeneti.html 2021-12-23T05:05:50+08:00 weekly 0.8 https://srla.jiuyuangene.net/ap/anticoagulant-api/enoxaparin-sodium-anticoagulant-and.html 2023-04-25T17:18:11+08:00 weekly 0.8 https://srla.jiuyuangene.net/ap/anticoagulant-api/avatrombopag-maleate-thrombocytopenia-cas-n.html 2025-02-23T07:29:02+08:00 weekly 0.8 https://srla.jiuyuangene.net/finished-dosage-form/recombinant-diabetes-injection/semaglutide-intermediate-totally-29-amino.html 2025-02-23T07:29:06+08:00 weekly 0.8 https://srla.jiuyuangene.net/finished-dosage-form/recombinant-diabetes-injection/amylin-analog-cas-no-138398-61-5.html 2025-02-23T07:29:07+08:00 weekly 0.8 https://srla.jiuyuangene.net/finished-dosage-form/oncology-injection/romosozumab-injection-osteoporosis-cas-909395.html 2025-02-22T14:49:01+08:00 weekly 0.8 https://srla.jiuyuangene.net/finished-dosage-form/oncology-injection/sirp-specific-monoclonal-antibody.html 2025-02-23T07:29:07+08:00 weekly 0.8 https://srla.jiuyuangene.net/ap/oncology-api/recombinant-human-hyaluronidase-cas-37326-33.html 2025-02-23T07:29:12+08:00 weekly 0.8 https://srla.jiuyuangene.net/ap/oncology-api/romosozumab-osteoporosis-cas-909395-70-6.html 2025-02-23T07:29:17+08:00 weekly 0.8 https://srla.jiuyuangene.net/finished-dosage-form/oncology-injection/daratumumab-with-recombinant-huma.html 2025-02-23T07:29:16+08:00 weekly 0.8 https://srla.jiuyuangene.net/ap/medical-device-api/bone-repair-material-with-rhbmp-2-bone-repair.html 2025-02-23T07:29:22+08:00 weekly 0.8 https://srla.jiuyuangene.net/ap/oncology-api/daratumumab-with-recombinant-humans.html 2025-02-23T07:29:27+08:00 weekly 0.8 https://srla.jiuyuangene.net/ap/medical-device-api/bone-repair-material-with-rhbmp-2-bone-repai.html 2026-01-15T01:00:10+08:00 weekly 0.8 https://srla.jiuyuangene.net/news/what-is-enoxaparin-sodium-52981264.html 2026-01-15T01:00:10+08:00 weekly 0.8 https://srla.jiuyuangene.net/news/preparation-method-of-enoxaparin-sodium-52981265.html 2026-01-15T01:00:10+08:00 weekly 0.8 https://srla.jiuyuangene.net/news/related-definitions-of-enoxaparin-sodium-52981266.html 2026-01-15T01:00:10+08:00 weekly 0.8 https://srla.jiuyuangene.net/news/pharmacological-effects-of-enoxaparin-sodium-52981267.html 2026-01-15T01:00:10+08:00 weekly 0.8 https://srla.jiuyuangene.net/news/pharmacokinetics-of-enoxaparin-sodium-52981268.html 2026-01-15T01:00:10+08:00 weekly 0.8 https://srla.jiuyuangene.net/news/adverse-reactions-of-enoxaparin-sodium-52981269.html 2026-01-15T01:00:10+08:00 weekly 0.8 https://srla.jiuyuangene.net/news/precautions-for-the-use-of-enoxaparin-sodium-52981270.html 2026-01-15T01:00:10+08:00 weekly 0.8 https://srla.jiuyuangene.net/news/usage-and-dosage-of-enoxaparin-sodium-52981271.html 2026-01-15T01:00:10+08:00 weekly 0.8 https://srla.jiuyuangene.net/news/interactions-between-enoxaparin-sodium-and-oth-52981272.html 2026-01-15T01:00:10+08:00 weekly 0.8 https://srla.jiuyuangene.net/news/precautions-for-using-palonosetron-hydrochlori-52981273.html 2026-01-15T01:00:10+08:00 weekly 0.8 https://srla.jiuyuangene.net/news/experts-comments-on-enoxaparin-sodium-52981274.html 2026-01-15T01:00:10+08:00 weekly 0.8 https://srla.jiuyuangene.net/news/medication-for-pregnant-and-lactating-women-52981275.html 2026-01-15T01:00:10+08:00 weekly 0.8 https://srla.jiuyuangene.net/news/palonosetron-hydrochloride-drug-interactions-52981276.html 2026-01-15T01:00:10+08:00 weekly 0.8 https://srla.jiuyuangene.net/news/palonosetron-hydrochloride-overdose-reaction-52981277.html 2026-01-15T01:00:10+08:00 weekly 0.8 https://srla.jiuyuangene.net/news/the-role-and-use-of-filgrastim-52981278.html 2026-01-15T01:00:10+08:00 weekly 0.8 https://srla.jiuyuangene.net/news/liraglutide-ingredients-52981279.html 2026-01-15T01:00:10+08:00 weekly 0.8 https://srla.jiuyuangene.net/news/usage-of-liraglutide-52981280.html 2026-01-15T01:00:10+08:00 weekly 0.8 https://srla.jiuyuangene.net/news/the-interaction-of-liraglutide-with-other-drug-52981281.html 2026-01-15T01:00:10+08:00 weekly 0.8 https://srla.jiuyuangene.net/news/liraglutide-dosage-requirements-52981282.html 2026-01-15T01:00:10+08:00 weekly 0.8 https://srla.jiuyuangene.net/news/what-is-the-reaction-of-an-overdose-of-liraglu-52981283.html 2026-01-15T01:00:10+08:00 weekly 0.8 https://srla.jiuyuangene.net/news/what-is-a-good-staple-food-for-diabetes-these-54539885.html 2022-03-07T23:47:53+08:00 weekly 0.8 https://srla.jiuyuangene.net/news/what-can-cancer-patients-eat-to-improve-immuni-54632257.html 2026-01-15T01:00:10+08:00 weekly 0.8 https://srla.jiuyuangene.net/news/new-hope-for-cancer-patients-intratumoral-inj-55719698.html 2022-04-27T14:24:16+08:00 weekly 0.8 https://srla.jiuyuangene.net/news/what-foods-are-good-for-diabetes-eat-more-of-56245614.html 2022-05-14T11:02:05+08:00 weekly 0.8 https://srla.jiuyuangene.net/news/what-can-cancer-patients-eat-to-improve-immuni-57044736.html 2022-07-04T13:52:17+08:00 weekly 0.8 https://srla.jiuyuangene.net/news/fulvestrant-news-58719743.html 2023-09-26T11:49:47+08:00 weekly 0.8 https://srla.jiuyuangene.net/news/what-is-oncology-injectables-71333101.html 2023-09-26T11:49:53+08:00 weekly 0.8 https://srla.jiuyuangene.net/news/what-are-oncology-drugs-used-for-71333102.html 2026-01-15T01:00:10+08:00 weekly 0.8 https://srla.jiuyuangene.net/news/what-is-the-difference-between-insulin-and-rec-77137361.html 2026-01-15T01:00:10+08:00 weekly 0.8 https://srla.jiuyuangene.net/news/what-are-the-5-types-of-insulin-injection-77137364.html 2026-01-15T01:00:10+08:00 weekly 0.8 https://srla.jiuyuangene.net/news/attending-cphi-china-78875562.html 2026-01-15T01:00:10+08:00 weekly 0.8 https://srla.jiuyuangene.net/news/jiuyuan-gene-will-attend-cphi-china-82405690.html 2025-03-27T01:38:46+08:00 weekly 0.8 https://srla.jiuyuangene.net/news/the-blockbuster-product-semaglutide-biosimila-17287119021974528.html 2025-03-27T01:39:07+08:00 weekly 0.8 https://srla.jiuyuangene.net/news/liu-jie-deputy-secretary-of-the-provincial-pa-17287119471977472.html 2025-03-27T01:39:13+08:00 weekly 0.8 https://srla.jiuyuangene.net/news/liu-jie-deputy-secretary-of-the-provincial-p-17287119554749440.html 2025-03-27T01:40:59+08:00 weekly 0.8 https://srla.jiuyuangene.net/news/what-is-recombinant-diabetes-injection-17287120718586880.html 2025-03-27T01:41:01+08:00 weekly 0.8 https://srla.jiuyuangene.net/news/how-does-recombinant-diabetes-injection-work-17287120979092480.html 2025-08-28T07:43:19+08:00 weekly 0.8 https://srla.jiuyuangene.net/news/top-chinese-oncology-api-manufacturers-17505408468263936.html 2025-10-18T06:47:47+08:00 weekly 0.8 https://srla.jiuyuangene.net/news/top-10-finished-dosage-form-manufacturers-in-c-17577528077771776.html 2025-12-17T13:12:32+08:00 weekly 0.8 https://srla.jiuyuangene.net/news/premier-manufacturers-of-medical-device-apis-i-17662935856063488.html 2026-01-15T01:00:10+08:00 weekly 0.8 https://srla.jiuyuangene.net/news/pegfilgrastim-pegylated-human-granulocyte-stim-17672385474421760.html 2026-01-15T01:00:10+08:00 weekly 0.8 https://srla.jiuyuangene.net/news/rhbmp-2-officially-approved-for-marketing-in-i-17672391178937344.html 2022-04-23T21:24:44+08:00 weekly 0.8 https://srla.jiuyuangene.net/info/representative-products-and-clinical-uses-of-h-69567432.html 2022-04-23T21:21:08+08:00 weekly 0.8 https://srla.jiuyuangene.net/info/introduction-of-bone-defect-repair-materials-69567423.html 2021-12-23T05:05:51+08:00 weekly 0.8 https://srla.jiuyuangene.net/info/enoxaparin-sodium-injection-site-65391235.html 2021-12-23T05:05:51+08:00 weekly 0.8 https://srla.jiuyuangene.net/info/the-effect-of-enoxaparin-sodium-on-pregnant-wo-65391234.html 2021-12-23T05:05:51+08:00 weekly 0.8 https://srla.jiuyuangene.net/info/the-difference-between-enoxaparin-sodium-and-l-65391233.html 2021-12-23T05:05:51+08:00 weekly 0.8 https://srla.jiuyuangene.net/info/low-molecular-weight-heparin-sodium-injection-65391232.html 2021-12-23T05:05:51+08:00 weekly 0.8 https://srla.jiuyuangene.net/info/how-about-enoxaparin-sodium-injection-65391231.html 2021-12-23T05:05:51+08:00 weekly 0.8 https://srla.jiuyuangene.net/info/does-enoxaparin-sodium-have-a-pregnancy-preser-65391230.html 2021-12-23T05:05:51+08:00 weekly 0.8 https://srla.jiuyuangene.net/info/effect-of-enoxaparin-sodium-injection-65391229.html 2021-12-23T05:05:51+08:00 weekly 0.8 https://srla.jiuyuangene.net/info/liraglutide-injection-several-times-a-day-65391228.html 2021-12-23T05:05:51+08:00 weekly 0.8 https://srla.jiuyuangene.net/info/contraindications-for-injection-of-liraglutide-65391227.html 2021-12-23T05:05:51+08:00 weekly 0.8 https://srla.jiuyuangene.net/info/liraglutide-discontinuation-sequelae-65391226.html 2021-12-23T05:05:51+08:00 weekly 0.8 https://srla.jiuyuangene.net/info/adverse-effects-of-liraglutide-for-weight-loss-65391225.html 2021-12-23T05:05:51+08:00 weekly 0.8 https://srla.jiuyuangene.net/info/side-effects-of-using-liraglutide-65391224.html 2021-12-23T05:05:51+08:00 weekly 0.8 https://srla.jiuyuangene.net/info/is-liraglutide-insulin-65391223.html 2021-12-23T05:05:51+08:00 weekly 0.8 https://srla.jiuyuangene.net/info/the-difference-between-liraglutide-and-insulin-65391222.html 2021-12-23T05:05:51+08:00 weekly 0.8 https://srla.jiuyuangene.net/info/precautions-for-fulvestrant-65391221.html 2021-12-23T05:05:51+08:00 weekly 0.8 https://srla.jiuyuangene.net/info/the-weight-loss-principle-of-liraglutide-65391220.html 2021-12-23T05:05:51+08:00 weekly 0.8 https://srla.jiuyuangene.net/info/pharmacokinetics-of-fulvestrant-65391219.html 2021-12-23T05:05:51+08:00 weekly 0.8 https://srla.jiuyuangene.net/info/the-pharmacological-effects-of-fulvestrant-65391218.html 2021-12-23T05:05:51+08:00 weekly 0.8 https://srla.jiuyuangene.net/info/liraglutide-storage-method-65391217.html 2021-12-23T05:05:51+08:00 weekly 0.8 https://srla.jiuyuangene.net/info/the-pharmacological-effects-of-liraglutide-65391216.html